1,4-phenylenebis(methylene)selenocyanate has been researched along with cyanates in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (66.67) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Conaway, CC; el-Bayoumy, K; Kurtzke, C; Marcus, LA; Meschter, CL; Upadhyaya, P | 1 |
| el-Bayoumy, K; Ganther, H; Ip, C; Thompson, H; Upadhyaya, P; Vadhanavikit, S | 1 |
| El-Bayoumy, K; Pittman, B; Rao, CV; Reddy, BS; Rivenson, A; Upadhyaya, P | 1 |
| El-Bayoumy, K; Guengerich, FP; Shimada, T; Sutter, TR; Upadhyaya, P; Yamazaki, H | 1 |
| Amin, S; Bewley, MC; Chen, KM; Das, A; De Cotiis, DA; Desai, D; El-Bayoumy, K; Fiala, ES; Flanagan, JM; Spratt, TE; Stanley, BA | 1 |
| Guengerich, FP; Komori, M; Murayama, N; Shimada, T; Takenaka, S; Tanaka, K; Yamazaki, H | 1 |
6 other study(ies) available for 1,4-phenylenebis(methylene)selenocyanate and cyanates
| Article | Year |
|---|---|
Subchronic toxicity of benzyl selenocyanate and 1,4-phenylenebis(methylene)selenocyanate in F344 rats.
Topics: Animals; Antineoplastic Agents; Body Weight; Cyanates; Dose-Response Relationship, Drug; Female; Kidney; Liver; Male; Organ Size; Organoselenium Compounds; Rats; Rats, Inbred F344 | 1992 |
Comparative effect of inorganic and organic selenocyanate derivatives in mammary cancer chemoprevention.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Biological Availability; Cyanates; Dose-Response Relationship, Drug; Female; Mammary Neoplasms, Experimental; Organoselenium Compounds; Rats; Rats, Sprague-Dawley; Sodium Selenite | 1994 |
Chemoprevention of colon cancer by organoselenium compounds and impact of high- or low-fat diets.
Topics: Adenocarcinoma; Analysis of Variance; Animals; Anticarcinogenic Agents; Azoxymethane; Colonic Neoplasms; Cyanates; Dietary Fats; Dose-Response Relationship, Drug; Incidence; Logistic Models; Male; Neoplasm Invasiveness; Organoselenium Compounds; Rats; Rats, Inbred F344 | 1997 |
Inhibition of human cytochrome P450-catalyzed oxidations of xenobiotics and procarcinogens by synthetic organoselenium compounds.
Topics: Animals; Anthracenes; Anticarcinogenic Agents; Benzyl Compounds; Carcinogens; Cyanates; Cytochrome P-450 CYP1A1; Cytochrome P-450 CYP1A2; Cytochrome P-450 Enzyme System; Humans; Male; Microsomes; Microsomes, Liver; Organoselenium Compounds; Oxazines; Oxidation-Reduction; Rats; Rats, Sprague-Dawley; Saccharomyces cerevisiae; Salmonella typhimurium; Sodium Selenite; Xenobiotics | 1997 |
Inhibition of nuclear factor-kappaB DNA binding by organoselenocyanates through covalent modification of the p50 subunit.
Topics: Amino Acid Sequence; Anticarcinogenic Agents; Cyanates; Dithiothreitol; DNA; Humans; Mass Spectrometry; Models, Molecular; Molecular Sequence Data; NF-kappa B; NF-kappa B p50 Subunit; Organoselenium Compounds | 2007 |
Spectral modification and catalytic inhibition of human cytochromes P450 1A1, 1A2, 1B1, 2A6, and 2A13 by four chemopreventive organoselenium compounds.
Topics: Animals; Antineoplastic Agents; Aryl Hydrocarbon Hydroxylases; Binding Sites; Biocatalysis; Catalytic Domain; Computer Simulation; Cyanates; Cytochrome P-450 CYP1A1; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP1A2 Inhibitors; Cytochrome P-450 CYP1B1; Cytochrome P-450 CYP2A6; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Humans; Neoplasms; Organoselenium Compounds; Protein Binding; Rats | 2011 |